Literature DB >> 26753712

Rapid Colorimetric Antibody Detection Using a Dual-function Peptide Probe for Silver Nanoparticle Aggregation and Antibody Recognition.

Mina Okochi1, Tomohiro Kamiya, Takeshi Omasa, Masayoshi Tanaka, Hiroyuki Honda.   

Abstract

Simple and rapid tools for antibody detection are beneficial for therapeutic monoclonal antibody development. Using a synthetic cationic antibody-recognizing peptide, a label-free colorimetric assay for antibody detection was established, in which a solution containing silver nanoparticles (AgNPs) changes color depending on particle aggregation/dispersion. Among the peptide probes we previously screened as IgG binding, one (NKFRGKYK) has four cationic amino acids and a pI of 10.46. Hence, we hypothesized that the peptide would both bind IgG and induce anionic AgNP aggregation via electrostatic interactions. This dual functionality of the IgG binding peptide could be useful for colorimetric detection. The detection of IgG in a solution containing culture media was investigated, and IgG was successfully detected at 100 to 500 nM within 2 min. This method is promising for high-throughput selection of IgG-producing cells since it is fast, readily observable, and does not involve complicated nanoparticle functionalization.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26753712     DOI: 10.2116/analsci.32.93

Source DB:  PubMed          Journal:  Anal Sci        ISSN: 0910-6340            Impact factor:   2.081


  2 in total

1.  Rational screening of biomineralisation peptides for colour-selected one-pot gold nanoparticle syntheses.

Authors:  M Tanaka; Y Takahashi; L Roach; K Critchley; S D Evans; M Okochi
Journal:  Nanoscale Adv       Date:  2018-08-20

2.  Screening and characterisation of CdTe/CdS quantum dot-binding peptides for material surface functionalisation.

Authors:  Thanawat Suwatthanarak; Masayoshi Tanaka; Taisuke Minamide; Andrew J Harvie; Abiral Tamang; Kevin Critchley; Stephen D Evans; Mina Okochi
Journal:  RSC Adv       Date:  2020-02-26       Impact factor: 4.036

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.